← Eichor
Study identifier: NCT06488807 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment

Condition: Perioperative Neurocognitive Disorder  ·  Sponsor: Shanghai 10th People's Hospital

PhaseNA
Planned participants686
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

Perioperative neurocognitive disorder (PND) is one of the most common postoperative complications among elderly patients. However, the mechanism and targeted intervention of PND remains unclear. Our previous clinical studies demonstrated the association between olfactory impairment and PND. Moreover, our translational studies showed that anesthesia/surgery induced olfactory impairment and caused cognitive impairment in mice and olfactory enrichment could prevent the anesthesia/surgery-induced cognitive impairment. However, there was no clinical investigation to determine whether olfactory enrichment can mitigate PND in elderly patients. Therefore, we propose determining whether olfactory enrichment can prevent and/or treat PND in elderly patients.

This description comes directly from the study's public registry record.

Talk to the study team

Yuan Shen  ·  +8618602169932  ·  dr.yuanshen@foxmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Tenth People's HospitalShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06488807